VeriMom¿Es s-silkworm oligopeptide-1 sp seguro durante el embarazo?
No harmonised CLP reproductive classification nor SCCS/CIR safety flags found for oligopeptide-1 or silk-derived peptides. Peer-reviewed literature on topical EGF/oligopeptides indicates local skin activity with minimal systemic exposure, and no evidence of reproductive toxicity in the cosmetic safety literature (CIR/SCCS absent). Therefore default hazard/mechanism scores are 0 and estimated exposure from topical use is negligible (e=0). Sources: CIR (no assessment indicating repro hazard), SCCS absence, PubMed literature on topical EGF safety, CosIng/PubChem listings.
Related ingredients
Frequently asked questions
- ¿Es s-silkworm oligopeptide-1 sp seguro durante el embarazo?
- No harmonised CLP reproductive classification nor SCCS/CIR safety flags found for oligopeptide-1 or silk-derived peptides. Peer-reviewed literature on topical EGF/oligopeptides indicates local skin activity with minimal systemic exposure, and no evidence of reproductive toxicity in the cosmetic safety literature (CIR/SCCS absent). Therefore default hazard/mechanism scores are 0 and estimated exposure from topical use is negligible (e=0). Sources: CIR (no assessment indicating repro hazard), SCCS absence, PubMed literature on topical EGF safety, CosIng/PubChem listings.
- ¿Es s-silkworm oligopeptide-1 sp seguro durante la lactancia?
- No evidence of breastmilk transfer or systemic reproductive/breastfeeding-specific toxicity for silk-derived oligopeptides; peptides applied topically generally show low systemic bioavailability, so risk to nursing infants is not indicated. Sources: PubMed on topical peptide absorption, CosIng/PubChem entries; no regulatory flags (ECHA Annex VI/CIR).
- ¿Es s-silkworm oligopeptide-1 sp seguro para la piel del bebé?
- Hazard and mechanism remain 0 (no data indicating reproductive/developmental toxicity). Exposure increased by one level for infants because immature skin barrier and higher surface-area-to-weight can increase systemic uptake; while adult dermal absorption is expected negligible, baby exposure is considered low but measurable (e=1). No infant-specific toxicity data found. Sources: general dermal absorption principles in peer-reviewed literature; regulatory databases (CosIng, PubChem); absence of adverse classifications (ECHA Annex VI/CIR).
- ¿Cómo puntúa VeriMom a s-silkworm oligopeptide-1 sp?
- VeriMom puntúa s-silkworm oligopeptide-1 sp en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a s-silkworm oligopeptide-1 sp en el embarazo?
- Consulta nuestra lista de alternativas seguras a s-silkworm oligopeptide-1 sp según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.